Gate2Brain as alumni at Caixa Impulse Validate

CaixaImpuls

On Monday 4th of October, Gate2Brain gave a talk at the Caixa Impulse Validate session. An acceleration program that provides support to early-stage biomedical research projects to help them validate their asset and define their valorization plan.

Two years ago, Gate2Brain was at this same session as an early-stage biotech being part of the program. Today, our CEO, Meritxell Teixidó, was invited alumni to explain Gate2Brain’s initial steps in its entrepreneurial journey to bring medicines beyond barriers.

An excellent session of exchange and networking brewing talent and innovative projects.

/by
You might also like
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient care Gate2Brain at MIT Pitch Day at University of Cambridge
medicines beyond barriersG2B Medicines beyond barriers
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation
EITHealth Catapult 2022eithealth Gate2Brain semifinalist of EITHealth’s Catapult 2022
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala Vanguardia Gate2Brain one of the winners of the South Summit Health & Well-being
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies. Gate2Brain will be attending The Investment Readiness Series
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Gate2Brain attending BioSpain 2021 BioSpain2021 Pediatric Innovation Dayi4kids Pediatric Innovation Day